Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019

Key Points

Question  Are rates of severe influenza disease associated with race and ethnicity?

Findings  In this cross-sectional study of influenza-associated outcomes among 113 352 patients hospitalized with influenza over the course of 10 influenza seasons, Black, Hispanic, and American Indian or Alaska Natives persons had higher rates of hospitalization and intensive care unit admission, even after adjusting for age. The greatest disparities were found in the youngest age groups.

Meaning  These findings suggest that targeted prevention and intervention efforts, such as improved influenza vaccine coverage and early use of antiviral treatment, could improve influenza-associated outcomes among racial and ethnic minority groups identified in this study as having higher rates of severe influenza disease.

Importance  Racial and ethnic minority groups, such as Black, Hispanic, American Indian or Alaska Native, and Asian or Pacific Islander persons, often experience higher rates of severe influenza disease.

Objective  To describe rates of influenza-associated hospitalization, intensive care unit (ICU) admission, and in-hospital death by race and ethnicity over 10 influenza seasons.

Design, Setting, and Participants  This cross-sectional study used data from the Influenza-Associated Hospitalization Surveillance Network (FluSurv-NET), which conducts population-based surveillance for laboratory-confirmed influenza-associated hospitalizations in selected counties, representing approximately 9% of the US population. Influenza hospitalizations from the 2009 to 2010 season to the 2018 to 2019 season were analyzed. Data were analyzed from October 2020 to July 2021.

Main Outcomes and Measures  The main outcomes were age-adjusted and age-stratified rates of influenza-associated hospitalization, ICU admission, and in-hospital death by race and ethnicity overall and by influenza season.

Results  Among 113 352 persons with an influenza-associated hospitalization (34 436 persons [32.0%] aged ≥75 years; 61 009 [53.8%] women), 70 225 persons (62.3%) were non-Hispanic White (White), 24 850 persons (21.6%) were non-Hispanic Black (Black), 11 903 persons (10.3%) were Hispanic, 5517 persons (5.1%) were non-Hispanic Asian or Pacific Islander, and 857 persons (0.7%) were non-Hispanic American Indian or Alaska Native. Among persons aged younger than 75 years and compared with White persons of the same ages, Black persons were more likely to be hospitalized (eg, age 50-64 years: rate ratio [RR], 2.50 95% CI, 2.43-2.57) and to be admitted to an ICU (eg, age 50-64 years: RR, 2.09; 95% CI, 1.96-2.23). Among persons aged younger than 50 years and compared with White persons of the same ages, American Indian or Alaska Native persons were more likely to be hospitalized (eg, age 18-49 years: RR, 1.72; 95% CI, 1.51-1.96) and to be admitted to an ICU (eg, age 18-49 years: RR, 1.84; 95% CI, 1.40-2.42). Among children aged 4 years or younger and compared with White children, hospitalization rates were higher in Black children (RR, 2.21; 95% CI, 2.10-2.33), Hispanic children (RR, 1.87; 95% CI, 1.77-1.97), American Indian or Alaska Native children (RR, 3.00; 95% CI, 2.55-3.53), and Asian or Pacific Islander children (RR, 1.26; 95% CI, 1.16-1.38), as were rates of ICU admission (Black children: RR, 2.74; 95% CI, 2.43-3.09; Hispanic children: RR, 1.96; 95% CI, 1.73-2.23; American Indian and Alaska Native children: RR, 3.51; 95% CI, 2.45-5.05). In this age group and compared with White children, in-hospital death rates were higher among Hispanic children (RR, 2.98; 95% CI, 1.23-7.19), Black children (RR, 3.39; 95% CI, 1.40-8.18), and Asian or Pacific Islander children (RR, 4.35; 95% CI, 1.55-12.22). Few differences were observed in rates of severe influenza-associated outcomes by race and ethnicity among adults aged 75 years or older. For example, in this age group, compared with White adults, hospitalization rates were slightly higher only among Black adults (RR, 1.05; 95% CI 1.02-1.09). Overall, Black persons had the highest age-adjusted hospitalization rate (68.8 [95% CI, 68.0-69.7] hospitalizations per 100 000 population) and ICU admission rate (11.6 [95% CI, 11.2-11.9] admissions per 100 000 population).

Conclusions and Relevance  This cross-sectional study found racial and ethnic disparities in rates of severe influenza-associated disease. These data identified subgroups for whom improvements in influenza prevention efforts could be targeted.

The burden of influenza in the United States is substantial, and annual influenza epidemics result in 140 000 to 810 000 hospitalizations and 12 000 to 61 000 deaths each year.¹ The ongoing COVID-19 pandemic has highlighted striking racial and ethnic disparities in COVID-19–associated morbidity and mortality^2-7 and raised important questions about racial and ethnic disparities associated with other respiratory viral infections, including influenza. Prior research has shown that owing, in part, to limitations of public health infrastructure and disparities in health care, pandemic influenza outbreaks are likely to disproportionately affect socially disadvantaged persons in the United States.⁸ During the 2009 influenza A H1N1 pandemic, racial and ethnic disparities in influenza-associated hospitalizations and pediatric deaths were identified,⁹ and non-Hispanic American Indian or Alaska Native persons were found to have 3- to 8-fold higher hospitalization and death rates associated with influenza A(H1N1)pdm09 compared with other racial and ethnic groups.¹⁰ Since that time, non-Hispanic American Indian or Alaska Native persons have been considered by the Advisory Committee on Immunization Practices to be at increased risk for influenza-associated complications.¹¹ Disparities in seasonal influenza-associated hospitalizations have also been observed¹²; non-Hispanic Black persons have been reported to have 1.7-fold higher adjusted odds of hospitalization, and Hispanic or Latino persons have been reported to have 1.2-fold higher adjusted odds of hospitalization compared with non-Hispanic White persons in a study conducted during the 2009 to 2010 through 2013 to 2014 influenza seasons.¹³ However, recent comprehensive data on racial and ethnic differences in rates of influenza-associated hospitalizations in the United States are lacking. We analyzed data from the Centers for Disease Control and Prevention (CDC)’s Influenza-Associated Hospitalization Surveillance Network (FluSurv-NET) to estimate rates of influenza-associated hospitalization, intensive care unit (ICU) admission, and in-hospital death by race and ethnicity over 10 influenza seasons (2009-2010 through 2018-2019).

FluSurv-NET surveillance activities were reviewed by CDC and were conducted consistent with applicable federal law and CDC policy (eg, 45 CFR. part 46.102[l][2], 21 CFR part 56; 42 USC §241[d]; 5 USC §552a; 44 USC §3501 et seq.). Sites participating in FluSurv-NET obtained approval from their respective state and local institutional review boards, as applicable. The requirement for informed consent was waived per 45 CFR 46. This study is reported following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.

FluSurv-NET, which has been previously described,¹⁴ conducts all-age population-based surveillance for laboratory-confirmed influenza-associated hospitalizations in selected counties in states that participate in the Emerging Infections Program and Influenza Hospitalization Surveillance Project (eFigure 1 in the Supplement). Emerging Infections Program sites include selected counties in California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee, while Influenza Hospitalization Surveillance Project sites include selected counties in Idaho (2009-2010 to 2010-2011 only), Iowa (2009-2010 and 2012-2013 only), Michigan, North Dakota (2009-2010 only), Ohio (2010-2011 to 2018-2019), Oklahoma (2009-2010 to 2010-2011 only), Rhode Island (2010-2011 to 2012-2013 only), South Dakota (2009-2010 only) and Utah (2010-2011 to 2018-2019). Approximately 25 to 29 million persons (8%-9% of the US population) were in the catchment of this surveillance system across these seasons.

Persons met the FluSurv-NET inclusion criteria if they were a resident of the FluSurv-NET catchment area, had a hospital admission date between October 1 and April 30 (or April 15, 2009, through April 30, 2010, during the 2009 influenza A H1N1 pandemic season), and had a positive influenza test no more than 14 days prior to or during hospitalization. Influenza testing was ordered at the discretion of health care practitioners, and laboratory confirmation was defined by a positive test result from rapid antigen diagnostic testing, molecular assay, indirect or direct fluorescent antibody assay, or viral culture. Trained surveillance staff conducted medical record abstractions using a standardized data collection form to obtain information on demographics, including age, sex, race and ethnicity, underlying medical conditions, antiviral treatment, and outcomes, including ICU admission and in-hospital death.

Race and ethnicity data were obtained from multiple sources, including notifiable disease, laboratory, and hospital databases. In most cases, race and ethnicity is self-reported, but the source could not be confirmed in every case. We categorized race and ethnicity according to the National Center for Health Statistics categories as non-Hispanic White, non-Hispanic Black, Hispanic or Latino, non-Hispanic Asian or Pacific Islander, and non-Hispanic American Indian or Alaska Native. People of more than 1 race and ethnicity or unknown race and ethnicity are captured by surveillance but were excluded from this analysis, since population denominators were not available for these groups. People of any race (including unknown race) but of Hispanic ethnicity were classified as Hispanic. If ethnicity was unknown (16.9% of included persons) but race was available, persons were classified based on reported race but were assumed to be of non-Hispanic ethnicity.

A minimum data set (including age, surveillance site, hospital admission date, and positive influenza test result and date) was reported for all persons across all seasons. During the 2009 to 2010 through 2016 to 2017 influenza seasons, medical record abstractions were also performed for all persons. Because of high counts of laboratory-confirmed influenza-associated hospitalizations during the 2017 to 2018 and 2018 to 2019 seasons, an age- and site-stratified random sampling scheme was used to obtain detailed clinical data through medical record abstraction for a representative sample of adults aged 50 years or older in 2017 to 2018 and adults aged 65 years or older in 2018 to 2019, as previously described.¹⁵ Medical record abstractions were conducted for all patients younger than 50 years and all patients of any age who died during their hospitalization. Of 14 surveillance sites included during these 2 seasons, 7 opted to implement a sampling strategy during the 2017 to 2018 season and 6 used the sampling strategy during the 2018 to 2019 season (Table 1). Race and ethnicity (2017-2018) and clinical data (2017-2018 and 2018-2019) on underlying conditions, receipt of at least 1 dose of current season influenza vaccine (for patients aged ≥6 months), ICU admission status, and antiviral treatment were only collected for sampled persons.

For all seasons, sampled data were weighted using survey procedures in SAS statistical software version 9.4 (SAS Institute), in which the weight was the inverse probability of selection of a person for medical record abstraction. For seasons prior to 2017 to 2018, sample weights were equal to 1. For the 2017 to 2018 season, sampling rates ranged from 25% to 100% by age group and site, while in 2018 to 2019, sampling rates ranged from 50% to 100% (Table 1), yielding weights ranging from 1 to 4. The weighted distribution of demographic characteristics, underlying medical conditions, influenza vaccination receipt, and antiviral treatment were calculated by age group and race and ethnicity; unweighted sample sizes and weighted percentages are presented.

Population denominators used for rate estimation were obtained from the National Center for Health Statistics bridged-race population estimates.¹⁶ These files have postcensal and intercensal estimates of the US resident population for the indicated years, by county, age, bridged race, Hispanic origin, and sex. For the 2010 to 2011 through 2018 to 2019 seasons, Vintage 2010 to 2018 postcensal estimates were applied. For the 2009 to 2010 season, the 2009 intercensal estimate was applied.

Unadjusted rates were calculated by dividing the weighted number of hospitalizations, ICU admissions, or in-hospital deaths by the total catchment population. Unadjusted rates were stratified by age group (0-4, 5-17, 18-49, 50-64, 65-74, and ≥75 years) and race and ethnicity. Unadjusted rates by race and ethnicity and age group were multiplied by the age distribution of the total FluSurv-NET catchment population to obtain age-adjusted rates; the age groups referenced previously were used for the age adjustment. We calculated 95% CIs for rates and rate ratios (RRs) assuming a simple random sample design and a normal distribution via the SAS STDRATE procedure. All analyses were conducted using SAS software. P values were 2-sided, and statistical significance was set at α = .05. Data were analyzed from October 2020 to July 2021.

Across all seasons, 131 908 persons hospitalized with influenza were identified, and of those 123 882 persons (93.9%) were sampled. Among the 123 882 sampled persons, 10 037 (8.1%) were excluded because race and ethnicity were unknown and 493 (0.4%) were excluded because they were classified as having more than 1 race and ethnicity. Table 1 displays the distribution of the remaining 113 352 persons (34 436 persons [32.0%] aged ≥75 years; 61 009 [53.8%] women) included in the analysis across seasons. Overall, the sample included 70 225 White persons (62.3%), 24 850 Black persons (21.6%), 11 903 Hispanic persons (10.3%), 5517 Asian or Pacific Islander persons (5.1%), and 857 American Indian or Alaska Native persons (0.7%). Among hospitalized persons, the prevalence of underlying conditions varied by age and race and ethnicity (eTable 1 in the Supplement). For example, compared with White children aged 17 years or younger, Black children had higher prevalence of asthma and blood disorders. Black persons and Hispanic persons had lower vaccination coverage compared with White persons in all age groups (eTable 1 in the Supplement). Differences in antiviral treatment were noted across age groups but not by race and ethnicity within the same age group (eTable 1 in the Supplement).

Unadjusted age-specific hospitalization (Figure 1) and ICU admission rates (eTable 2 in the Supplement) were highest among Black persons for all age groups except age 4 years or younger, in which hospitalization and ICU admission rates were highest among American Indian or Alaska Native persons. Compared with White persons, unadjusted hospitalization RRs varied by age group and were higher among Black persons younger than 75 years (eg, age 50-64 years: RR, 2.50, 95% CI, 2.43-2.57), American Indian or Alaska Native persons younger than 65 years (eg, age 18-49 years: RR, 1.72; 95% CI, 1.51-1.96), and Hispanic children aged 4 years or younger (RR, 1.87; 95% CI, 1.77-1.97) (Table 2). Compared with White persons, unadjusted ICU admission RRs were higher among Black persons younger than 75 years (eg, age 50-64 years: RR, 2.09; 95% CI, 1.96-2.23), American Indian or Alaska Native persons younger than 50 years (eg, age 18-49 years: RR, 1.84; 95% CI, 1.40-2.42), and Hispanic children younger than 4 years (RR, 1.96; 95% CI, 1.73-2.23) (Table 2).

Compared with White persons of the same age group, unadjusted death rates were higher among Black adults aged 50 to 64 years (RR, 1.53; 95% CI, 1.28-1.83), American Indian or Alaska Native adults aged 18 to 49 years (RR, 2.20; 95% CI, 1.04-4.67), and American Indian or Alaska Native children aged 5 to 17 years (RR, 4.17; 95% CI, 1.00-17.41) (Table 2). Among children aged 4 years or younger and compared with White children, unadjusted in-hospital death rates were higher among Hispanic children (RR, 2.98; 95% CI, 1.23-7.19), Black children (RR, 3.39; 95% CI, 1.40-8.18), and Asian or Pacific Islander children (RR, 4.35; 95% CI, 1.55-12.22) (Table 2).

Age-adjusted rates per 100 000 population of hospitalization, ICU admission and in-hospital death are displayed in Figure 2 eTable 3 in the Supplement. Age-adjusted RRs for hospitalization and ICU admission are presented in Table 3. Age-adjusted hospitalization and ICU admission RRs were higher in Black persons compared with White persons across all seasons (Table 3). During the 2009 influenza A H1N1 pandemic season, age-adjusted hospitalization rates compared with White persons were higher among American Indian or Alaska Native persons (RR, 1.82; 95% CI, 1.48-2.22) and Hispanic persons (RR, 1.89; 95% CI, 1.77-2.02), and ICU admission rates were higher among Hispanic persons (RR, 1.77; 95% CI, 1.53-2.04). During that same season, rates of in-hospital death were higher among Hispanic persons (RR, 1.87; 95% CI, 1.28-2.74) compared with White persons (Table 3).

Age-adjusted rates of hospitalization, ICU admission, and in-hospital death by race and ethnicity differed by surveillance site. While all sites experienced higher hospitalization and ICU admission rates in Black persons compared with White persons, only a few sites (ie, Colorado, Minnesota, and New Mexico) experienced higher hospitalization and ICU admission rates in American Indian or Alaska Native persons compared with White persons (eFigure 2 in the Supplement). Similarly, differences in rates of severe outcomes among Hispanic persons compared with White persons were most pronounced in certain sites (ie, Colorado, Connecticut, New Mexico, and Albany and Rochester, New York).

In this cross-sectional study using data from FluSurv-NET over the course of 10 influenza seasons, we identified age-stratum–specific racial and ethnic disparities in influenza-associated hospitalization, ICU admission, and in-hospital death rates, with the greatest disparities observed among younger age groups. Few rate differences were observed in adults aged 75 years or older across racial/ethnic groups. Among adults aged 18 to 64 years, hospitalization and ICU admission rates were higher for Black persons and American Indian or Alaska Native persons compared with White persons. Notably, differences in rates of hospitalization, ICU admission, and in-hospital deaths by race and ethnicity were greatest among children aged 4 years or younger. Overall, after adjusting for age, Black persons had the highest influenza-associated hospitalization rates, followed by American Indian or Alaska Native persons and Hispanic persons, with similar trends for ICU admission rates.

In our analysis, the most marked racial and ethnic disparities were observed for influenza-associated in-hospital deaths among children aged 4 years or younger. Black, Hispanic, and Asian or Pacific Islander children had 3- to 4-fold the rate of in-hospital death compared with White children. Consistent with our findings, reports using National Vital Statistics Surveillance mortality data have shown that disparities in pneumonia and influenza mortality are greatest in the youngest American Indian or Alaska Native children,¹⁷ and racial/ethnic disparities in infant and early life mortality have been identified for Black children and Hispanic children.^18,19

Across all age groups, we found that Black persons had the highest rates of hospitalization and ICU admission, followed by American Indian or Alaska Native persons and Hispanic persons. Our findings are similar to prior studies that have identified disparities in influenza-associated hospitalizations in children during 2002 through 2009 using data from the New Vaccine Surveillance Network,²⁰ and across all ages in 2 separate FluSurv-NET analyses.^12,13 In one FluSurv-NET analysis that examined hospitalization rates by race and ethnicity and census-tract poverty level during 2010 to 2012,¹² age-adjusted hospitalization rates were highest for Black persons; within each race and ethnicity group, hospitalization rates within high-poverty census tracts were nearly 2-fold the rates in low-poverty census tracts. Another analysis of FluSurv-NET data from 2009 to 2010 through 2013 to 2014 used a multilevel modeling approach to simultaneously assess individual-level and census tract–based determinants of influenza-associated hospitalization rates.¹³ In that analysis, individual factors associated with increased hospitalization rates included race (Black persons had 1.7-fold higher odds of hospitalization and Hispanic persons had 1.2-fold higher odds of hospitalization compared with White persons), and census tract–level factors included living in areas with higher levels of poverty and household crowding. However, outside of these earlier FluSurv-NET analyses and studies conducted during the 2009 influenza A H1N1 pandemic,^8,10,21 data are relatively limited on the association of race and ethnicity with recent rates of severe influenza-associate disease. To our knowledge, this is the largest analysis to date to examine disparities in rates of multiple severe influenza-associated outcomes across all racial and ethnic groups.

In our analysis, while rates of in-hospital death were similar across racial and ethnic groups when combining seasons, during the 2009 influenza A H1N1 pandemic season, rates of in-hospital mortality were highest in Hispanic persons, followed by American Indian or Alaska Native persons. Our findings are consistent with a 2009 H1N1 pandemic study by Dee et al,⁹ which found that the proportion of H1N1pdm09-associated pediatric deaths was disproportionately higher among Hispanic children compared with the distribution of Hispanic children in the US population. A study by Quinn et al²¹ found significant racial/ethnic disparities in exposure risk, susceptibility to complications, and access to care during the 2009 pandemic. Generally, it has been recognized that a pandemic influenza outbreak in the United States would likely disproportionately impact socially disadvantaged groups, and pandemic planning must consider exposure, susceptibility, and treatment of high-risk populations.⁸

Striking racial and ethnic disparities in COVID-19–associated hospitalization rates have been observed during the ongoing COVID-19 pandemic, with differences observed between non-Hispanic White persons and other racial and ethnic groups being far more pronounced than for both seasonal and 2009 H1N1 pandemic influenza. Compared with rates among White persons, cumulative COVID-19–associated hospitalization rates are approximately 3-fold higher in Hispanic persons aged 17 years or younger, 6-fold higher in American Indian or Alaska Native persons aged 18 to 49 years, 4-fold higher among American Indian or Alaska Native persons aged 50 to 64 years, and 2-fold higher among Black persons 65 years or older.²² Multiple studies have shown that racial and ethnic disparities associated with COVID-19 are likely due to inequities in social determinants of health among racial and ethnic minority groups. Contributing factors include lack of access to quality health care, disproportionate representation in essential occupations, and crowded living conditions, which may all increase exposure to COVID-19.^5-7,23-26 Future work should investigate whether racial and ethnic disparities in influenza-associated hospitalizations and outcomes are influenced by similar factors.

Seasonal influenza vaccination coverage disparities by race and ethnicity have been well-described,^27-30 which might partially explain why racial and ethnic minority groups, such as Black, Hispanic, Asian or Pacific Islander, and American Indian or Alaska Native populations, are disproportionately affected by severe influenza and also helps to identify critical gaps in influenza vaccination that need to be filled. Over multiple influenza seasons through 2015, vaccination coverage in the general population has been lower among Black and Hispanic adults compared with White adults, and Black and Hispanic children had lower rates of full vaccination coverage compared with White children^27-30; our findings in hospitalized patients of all ages showed similar disparities. Vaccination coverage has been shown to correlate with socioeconomic status,³¹ access to health care, and birth country, where those with greater access to care had higher vaccination coverage, and those born outside the United States had lower vaccination coverage compared with US-born persons.²⁹

This study has several limitations. First, FluSurv-NET conducts surveillance in selected counties within the United States, and findings may not represent the entire US population. Second, laboratory-confirmed influenza-associated hospitalizations reported to FluSurv-NET are identified by clinician-directed testing. Thus, hospitalization rates may be underestimated, since they have not been adjusted for testing practices, which are known to differ by surveillance site, age group, and timing during influenza seasons,³² and may also vary by race and ethnicity. Third, approximately 16% of persons were missing ethnicity and were classified based only on their reported race. Fourth, death rates reflect persons who died during their hospitalization, and our analysis did not capture influenza-associated deaths that occurred after hospital discharge. Preliminary analyses from FluSurv-NET indicate that deaths occurring within 30 days after discharge could account for a substantial burden of seasonal influenza-associated mortality, particularly among older adults.³³ Fifth, because these data were not available for the underlying source population, this analysis did not adjust rates for other factors, such as vaccination status, underlying medical conditions, receipt of antivirals, or illness severity at hospital admission, all of which could potentially impact findings.

This cross-sectional study identified racial and ethnic disparities in rates of influenza-associated hospitalization, ICU admission, and in-hospital death from the 2009 to 2010 through 2018 to 2019 influenza seasons, with the widest disparities occurring among young children from racial/ethnic minority groups, such as Black, Hispanic, and Asian or Pacific Islander children. These data could help target prevention and intervention efforts, such as improved influenza vaccine coverage and early use of antiviral treatment, to improve influenza-associated outcomes among racial and ethnic minority groups.

Accepted for Publication: June 13, 2021.

Published: August 24, 2021. doi:10.1001/jamanetworkopen.2021.21880

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 O’Halloran AC et al. JAMA Network Open.

Corresponding Author: Alissa C. O’Halloran, MSPH, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS H24-7, Atlanta, GA 30329 (idg3@cdc.gov).

Author Contributions: Ms O’Halloran and Ms Holstein had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: O’Halloran, Cummings, Alden, Anderson, Ryan, Bennett, Schaffner, Fry, Reed, Garg.

Acquisition, analysis, or interpretation of data: O’Halloran, Holstein, Daily Kirley, Alden, Yousey-Hindes, Anderson, Ryan, Kim, Lynfield, McMullen, Bennett, Spina, Billing, Sutton, Schaffner, Talbot, Price, Reed, Garg.

Drafting of the manuscript: O’Halloran, Anderson, Garg.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: O’Halloran, Holstein, Garg.

Obtained funding: Schaffner, Talbot.

Administrative, technical, or material support: Cummings, Daily Kirley, Alden, Ryan, Lynfield, Bennett, Spina, Sutton, Schaffner, Price, Reed.

Supervision: Daily Kirley, Anderson, Lynfield, Billing, Schaffner, Talbot, Fry, Reed, Garg.

Conflict of Interest Disclosures: Ms Alden reported receiving grants from Centers for Disease Control and Prevention (CDC) Emerging Infections Program Cooperative Agreement during the conduct of the study and grants from CDC Emerging Infections Program Cooperative Agreement outside the submitted work. Ms Yousey-Hindes reported receiving grants from CDC Emerging Infections Program received grant funding from CDC during the conduct of the study. Dr Anderson reported receiving grants from Pfizer, Sanofi Pasteur, MedImmune, Regeneron, PaxVax, GlaxoSmithKline, Merck, Janssen, and Micron and personal fees from Pfizer, Sanofi Pasteur, Medscape, and Kentucky Bioprocessing outside the submitted work. Ms Ryan reported receiving grants from the CDC Emerging Infections Program Cooperative Agreement during the conduct of the study. Ms Kim reported grants from Michigan Department of Health and Human Services during the conduct of the study. Dr Lynfield reported grants from the CDC Emerging Infections Program Cooperative Agreement during the conduct of the study, and receiving royalties from Wiley-Blackwell (donated to the Minnesota Department of Health), and serving as an assistant editor for the American Academy of Pediatrics Red Book. Ms Billing reported receiving grants from Council for State and Territorial Epidemiologists (CSTE), the CDC outside the submitted work. Dr Sutton reported receiving grants from the CDC Emerging Infections Program during the conduct of the study. Dr Schaffner reported grants from the CDC Emerging Infections Program Cooperative Agreement during the conduct of the study and personal fees from VBI Vaccines outside the submitted work. Dr Talbot reported receiving grants from the CDC during the conduct of the study. No other disclosures were reported.

Funding/Support: This work was supported by the Centers of Disease Control and Prevention (CDC) through an Emerging Infections Program cooperative agreement (grant No. CK17-1701) and through a Council of State and Territorial Epidemiologists cooperative agreement (grant No. NU38OT000297-02-00).

Role of the Funder/Sponsor: Ms O’Halloran, Ms Holstein, and Ms Cummings and Drs Fry, Reed, and Garg are employees of the CDC and had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; and decision to submit the manuscript for publication.

Disclaimer: The conclusions, findings, and opinions expressed in this work do not necessarily reflect the official position of the US Department of Health and Human Services, the US Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.

Additional Contributions: Susan Brookes, MPH; Ashley Coates, MPH; Linda Frank, RN, BSN, PHN; Deborah Godine, RN; Erin Parker, MPH; and Alison Ryan, MPH (California Emerging Infections Program); Rachel K. Herlihy, MD, MPH (Colorado Department of Public Health and Environment); Darcy Fazio, BA; Amber Maslar, MPA; James Meek, MPH; Adam Misiorski, MPH; Linda Niccolai, PhD; and Tamara Rissman, MPH (Connecticut Emerging Infections Program); Matthew Cartter, MD, MPH (Connecticut Department of Public Health); Robert Heimer, PhD (Yale School of Public Health); Emily Fawcett, MPH; Katelyn Lengacher, MPH; Kyle Openo, DrPH; Suzanne Segler, MPH; Stepy Thomas, MSPH; and Jeremiah Williams, MPH (Emerging Infections Program, Georgia Department of Health, Veterans Affairs Medical Center, Foundation for Atlanta Veterans Education and Research); Monica Farley, MD (Emerging Infections Program, Georgia Department of Health, Veterans Affairs Medical Center, Department of Medicine, Emory University School of Medicine); Maya Monroe (Maryland Department of Health); Jim Collins, MPH, RS; Sam Hawkins, BS; Justin Henderson, MPH; Shannon Johnson, MPH; Alex Kohrman, MPH; Libby Reeg, BA; and Val Tellez Nunez, BS (Michigan Department of Health and Human Services); Net Bekele, MLS; Sarah Bistrodeau, BS; Dave Buxrud, MS; Erica Bye, MPH; Larry Caroll, MLS; Jamie Christensen, BS; Katie Harry, MS; Cynthia Kenyon, MPH; Melissa McMahon, MPH; Craig Morin, MPH; Jennifer Palm, BS; Anna Strain, PhD; Angie Taylor, BS; Sara Vetter, PhD; and Jason Wotton, MA (Minnesota Department of Health); Salina Torres, PhD (New Mexico Department of Health); Kathy Angeles, MPH; Isaac Armistead, MPH; Lisa Butler, MPH; Sarah Khanlian, MPH; and Robert Mansmann, MPH (University of New Mexico Health Sciences Center); Kerianne Engesser, MPH, and Katarina Manzi, BS (New York State Department of Health); Sophrena Bushey, MHS; Christina Felsen, MPH; Maria Gaitan, BS; RaeAnne Kurtz, BS; and Christine Long, MPH (University of Rochester School of Medicine and Dentistry); Jess Shiltz, MPH (Ohio Department of Health); Ama Owusu-Domney, MPH, and Nicole West, MPH (Public Health Division, Oregon Health Authority); Katie Dyer; Karen Leib, RN; Tiffanie Markus, PhD; Terri McMinn; and Danielle Ndi, MPH (Vanderbilt University School of Medicine); Ian Buchta, MPH; Amanda Carter, BS; Ryan Chatelain, MPH; Andrea George, MPH; Andrew Haraghey, BS; Mary Hill, MPH; Laine McCullough, MPH; Jake Ortega, MPH; Caitlin Shaw, BS; Ashley Swain; Tyler Riedesel, MPH; Ilene Risk, MPA; and Melanie Crossland, MPH (Salt Lake County Health Department); and Keegan McCaffrey, BS (Utah Department of Health), contributed to data collection and surveillance activities. They were compensated for this work through grants from the Centers for Disease Control Emerging Infections Program (California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and Albany, and Rochester, New York) and Influenza Hospitalization Surveillance Project (Michigan, Ohio, and Utah).